HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Diffuse large B-cell non-Hodgkin's lymphoma presenting as a vaginal mass in a patient with a history of intestinal mucosa-associated lymphoid tissue (MALT) lymphoma.

Abstract
Vaginal involvement in non-Hodgkin's lymphoma is uncommon and is often secondary to disseminated disease. Primary disease at this site is quite rare. We present here an unusual case of a patient who developed a diffuse large B-cell lymphoma presenting as a vaginal mass after having been treated for primary intestinal mucosa-associated lymphoid tissue (MALT) lymphoma 4 years earlier. Combined chemotherapy and radiation therapy for the intestinal MALT lymphoma produced complete remission that lasted for 2 years. Chemotherapy given for the diffuse large B-cell lymphoma with secondary vaginal involvement produced a second complete remission. The second remission was consolidated with high-dose chemotherapy and autologous bone marrow transplantation. Although the patient died from complications related to the transplant procedure, the disease was in complete remission at the time of her death. Given the rarity of primary intestinal MALT lymphoma and primary vaginal lymphoma, no standard treatment has been established. Treatment options have included chemotherapy, radiation therapy, or surgery, given alone or in combination.
AuthorsC Hosing, R S Freedman, P McLaughlin, A Malpica, B D Fornage, A P Kudelka
JournalAmerican journal of clinical oncology (Am J Clin Oncol) Vol. 24 Issue 2 Pg. 204-8 (Apr 2001) ISSN: 0277-3732 [Print] United States
PMID11319299 (Publication Type: Case Reports, Clinical Conference, Journal Article)
Topics
  • Combined Modality Therapy
  • Female
  • Humans
  • Intestinal Neoplasms (therapy)
  • Lymphoma, B-Cell, Marginal Zone (therapy)
  • Lymphoma, Large B-Cell, Diffuse (diagnosis, pathology, therapy)
  • Middle Aged
  • Neoplasms, Second Primary (diagnosis, pathology, therapy)
  • Vaginal Neoplasms (diagnosis, pathology, therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: